Managing Complications of Chemotherapy Discussed on CME Webcast

OSUWexnerbloglogo2014 Managing Complications of Chemotherapy Discussed on CME Webcast. On this CME webcast, to update us is medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and the James Cancer Hospital, Dr. Erin Bertino. And also from the James Cancer Hospital, Assistant Professor of Internal Medicine, Dr. Edmund Folefac.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the differences in toxicity for three categories of oncology therapy: cytotoxic chemotherapy, targeted therapy, and immunotherapy; and UNDERSTAND basic management of the most common toxicities of chemotherapy, targeted therapy, and immunotherapy.

You’ll also learn about the following:

  • Evolution of targeted therapies and immunotherapy
  • What to expect with cancer treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care

OSUWexnerbloglogo2014 On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care. On this CME webcast, we’re going to learn about the special needs of cancer survivors. We’re delighted to welcome medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and James Cancer Hospital, Dr. Maryam Lustberg. And also general internist, pediatrician, and Assistant Professor of Internal Medicine from OSU, Dr. Heather Saha.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the needs of cancer survivors throughout the cancer continuum; DISCUSS way to improve PCP and oncologist collaboration and communication.

You’ll also learn about the following:

  • The role of the primary care physician in cancer survivorship
  • Managing fatigue in the cancer survivor
  • Special considerations for survivors of pediatric cancers
  • Healthy diets for cancer survivors
  • Chemotherapy and peripheral neuropathy
  • Radiation effects on long-term health
  • Economic and financial implications of being a cancer survivor
  • Cancer survivors and sexual health
  • Cancers that can have late relapse

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Cardiomyopathy

OSUWexnerbloglogo2014CME Webcasts Teaches on Cardiomyopathy. On this CME webcast, we are going to give you the information you need to be able to recognize cardiomyopathy in your patients and then to be able to identify the specific cause of their cardiomyopathy. Joining our moderator in the studio are two cardiologists from the Ohio State University. Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials at Ohio State. And Dr. Brent Lampert is an Assistant Professor of Internal Medicine and the Associate Program Director for the heart failure and transplant fellowship.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common presenting signs and symptoms of cardiomyopathy; and REVIEW the diagnostic work up for cardiomyopathy.

You’ll also learn about the following:

  • Common causes of cardiomyopathy
  • Initial diagnostic steps in cardiomyopathy
  • Follow up imaging in patients with cardiomyopathy
  • Myocardial sarcoidosis
  • Physical examination of hypertrophic cardiomyopathy
  • Takotsubo cardiomyopathy
  • Diagnosing restrictive cardiomyopathies
  • Significance and work up of diastolic dysfunction
  • Chemotherapy-induced cardiomyopathy
  • Chagas Disease (Trypanosoma infection)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.